Get my own profile
Public access
View all0 articles
2 articles
available
not available
Based on funding mandates
Co-authors
- Andrei LupasDirector of the Department of Protein Evolution, Max-Planck-Institute for BiologyVerified email at tuebingen.mpg.de
- James R BrownSelf-employedVerified email at drexel.edu
- Peter G. WolynesBullard-Welch Foundation Professor of Science, Professor of Chemistry, Professor of PhysicsVerified email at rice.edu
- Benjamin BaxResearch FellowVerified email at cardiff.ac.uk
- Zaida (Zan) Luthey-SchultenUniversity of Illinois at Urbana-ChampaignVerified email at illinois.edu
- Roiban Gheorghe-DoruGlaxoSmithKline plcVerified email at gsk.com
- Chaya DuraiswamiProduct Director (Safety & Efficacy), GlaxosmithklineVerified email at gsk.com
- Sergej DjuranovicProfessor of Cell Biology and Physiology, Washington UniversityVerified email at wustl.edu
- Rob RussellProfessor of Protein Evolution, BioQuant/BZH, Heidelberg University, GermanyVerified email at bioquant.uni-heidelberg.de
- Peter GoughInzen TherapeuticsVerified email at inzentx.com
- John D LichPharmaVerified email at gsk.com
- John BertinSanofiVerified email at sanofi.com
- Vikram AlvaMax Planck Institute for BiologyVerified email at tuebingen.mpg.de
- Philippe SanseauGSKVerified email at gsk.com
- Markus GruberNokia Bell LabsVerified email at nokia.com
- Peter TumminoChief Scientific Officer, Nimbus TherapeuticsVerified email at nimbustx.com
- Robert A. CopelandPresident & CSO, Accent Therapeutics, Inc.Verified email at accenttx.com